Wound Care Biologics Market Share

Global Wound Care Biologics Market Overview

Wound Care Biologics Market Size was valued at USD 1.90 Billion in 2023. The Global Wound Care Biologics industry is projected to grow from USD 2.10 Billion in 2024 to USD 2.40 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 14.76% during the forecast period (2024 - 2032).

Wound care biologics products help the body repair wounds naturally by creating an active healing environment. Diabetic ulcers, venous ulcers, arterial ulcers, and pressure ulcers are the most common wounds treated with biologics.

The wound care biologics market is predicted to develop due to reasons such as the rising prevalence of chronic illnesses and burn injuries, as well as rising healthcare spending. According to the Centers for Disease Control and Prevention (CDC), around 2.8 million persons were admitted to hospitals owing to injuries in 2015. Over the projection period, however, the wound care biologics market will be hampered by high treatment costs, a lack of awareness, and insufficient education and training.

Wound Care Biologics Market Segment Insights

The wound care biologics market has been segmented into product type, wound type, and end user.

Wound Care Biologics Product Type Insights

Based on product type, has been segmented into biological skin substitutes and topical agents. The biological skin substitutes segment is expected to account for the largest share and fastest growing segment of the market.

Wound Care Biologics Wound Type Insights

The market, by wound type, has been segmented into ulcers, surgical & traumatic wounds, and burns. The ulcers segment has been further segmented into diabetic foot ulcers, pressure ulcers, venous leg ulcer, and others.

Wound Care Biologics End User Insights

The market, by end user, has been segmented into hospitals, ambulatory surgical centers, and clinics.

Wound Care Biologics Regional Insights

The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The wound care biologics market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.

The European wound care biologics market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.

The wound care biologics market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The wound care biologics market in the Middle East & Africa has been segmented into the Middle East and Africa.

Key players

Some of the key players in the wound care biologics market are

• Integra LifeSciences Corporation (US)


• Smith & Nephew (UK)


• Wright Medical (US)


• Mölnlycke Health Care AB (Sweden)


• MiMedx Group (US)


• Vericel Corporation (US)


• Anika Therapeutics (US)


• Osiris Therapeutics (US)


• Marine Polymer Technologies, Inc. (US)


• Kerecis (Iceland)


• Solsys Medical (US)


• ACell (US)


• Organogenesis (US)

Regional Market Summary

Geographically, the Americas is anticipated to dominate the wound care biologics market owing to a well-developed healthcare sector, growing occurrences of chronic wounds, rising prevalence of diabetes and rising geriatric population. According to the National Diabetes Statistics Report 2017, about 30.3 million suffer from diabetes in Americans.

Europe is expected to hold the second largest position in the wound care biologics market. The market growth in this region is attributed to the increasing prevalence of diabetes and developed healthcare infrastructure.

The wound care biologics market in Asia-Pacific region consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia-Pacific. The Asia-Pacific region is expected to be the fastest growing region owing to the huge patient population of chronic diseases such as diabetes in countries such as India and China.

The Middle East & Africa has the least share of the market. Majority of the market of this region is expected to be held by the Middle East region due to a well-developed healthcare sector and growing government initiatives for the healthcare sector.

Recent Development

Wright Medical Group Inc. manufactures human replacement components. The company creates replacement joints for the foot, ankle, hand, elbow, shoulder, and other damaged joints. The IN BONE, CLAW, and ORTHOLOC systems for foot and ankles, as well as the MICRONAIL implants for wrist fractures, are among the product lines. Wright's goods are distributed in over 60 countries, with the United States being the main market. Wright Medical Group N.V. was formed in 2015 when the company merged with Tornier of the Netherlands.

MiMedx Group Inc. is a medical equipment manufacturer. Biomaterials for soft tissue repair, such as tendons, ligaments, and cartilage, are the company's main emphasis, as well as various biomaterial-based solutions for other medical purposes. The MiMedx Group is a global provider of medical services.

Intended Audience

• Wound Care Biologics Manufacturers and Vendors


• Various Research and Consulting Firms


• Wound Care Biologics Distributors


• Hospitals

Wound Care Biologics Market Segmentation

Wound Care Biologics Market Product Type Outlook

• Skin Substitute


• Human Donor Tissue


• Acellular animal-derived


• Biosynthetic


• Topical Agents

Wound Care Biologics Market Wound Type Outlook

• Ulcers


• Diabetic foot ulcers


• Venous ulcers


• Pressure ulcers


• Other ulcers


• Surgical and Traumatic Wounds


• Burns

Wound Care Biologics Market End User Outlook

• Hospitals


• Clinics


• Other End Users

Wound Care Biologics Market Region Outlook

• Americas

• 
  
  
  
  • North America
  
  
  • US
  
  
  • Canada
  
  
  • South America
  
  
  
  

• Europe

• 
  
  
  
  • Western Europe
  
  
  • Germany
  
  
  • France
  
  
  • Italy
  
  
  • Spain
  
  
  • UK
  
  
  • Rest of Western Europe
  
  
  • Eastern Europe
  
  
  
  

• Asia-Pacific

• 
  
  
  
  • Japan
  
  
  • China
  
  
  • India
  
  
  • Australia
  
  
  • South Korea
  
  
  • Rest of Asia-Pacific
  
  
  
  

• The Middle East & Africa

• 
  
  
  
  • Middle East
  
  
  • Africa